C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2002
12/12/2002	WO2002098868A1 Epothilone derivatives
12/12/2002	WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002	WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002	WO2002098429A1 Ethanolamine, diethanolamine or triethanolamine salt of zopolrestat
12/12/2002	WO2002098424A1 Novel anti-infectives
12/12/2002	WO2002081398A3 Additives for building industry obtained from by-products and process for their production
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	WO2002062792A9 Jnk inhibitor
12/12/2002	WO2002004424A9 Pyrazole derivatives
12/12/2002	WO2001097786A3 Benzothiazole derivatives
12/12/2002	US20020188131 Sulphonylbenzazolones
12/12/2002	US20020188015 Method and composition for rejuvinating cells, tissues organs, hair and nails
12/12/2002	US20020188014 Polymorphs of an epothilone analog
12/12/2002	US20020187987 Use of 2-aminothiazoline derivatives as inhibitors of inducible NO-synthase
12/12/2002	US20020187982 Glucagon antagonists/inverse agonists
12/12/2002	US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002	DE10125961A1 Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden Carbazole derivatives and their use for the preparation of a pharmaceutical composition for the treatment of related ailments associated with NPY
12/12/2002	CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	CA2449770A1 Novel anti-infectives
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449077A1 Epothilone derivatives
12/12/2002	CA2448824A1 Novel compounds for chemiluminescense procedures
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	CA2448370A1 Luciferin hydrazides
12/11/2002	EP1264826A1 Novel imidazoline compounds
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263747A1 1,5-benzothiazepines and their use as hypolipidaemics
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002	EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1100805B1 Medicine nitrate salts
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002	EP0722446B1 Distamycin a analogues as antitumour or antiviral agents
12/11/2002	CN1384832A Pesticidal aminoheterocyclamide compounds
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/11/2002	CN1095664C Thiadizoles compound and drug compositions and use thereof
12/10/2002	US6492404 Thiazolylcinnamonitriles and pest controlling agents
12/10/2002	US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof
12/10/2002	US6492402 Anticoagulants; peptide derivatives having high antithrombotic activity and oral bioavailability
12/10/2002	US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage
12/10/2002	US6492400 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/10/2002	US6492396 Substituted thioacetamides
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002	US6492365 Microsomal triglyceride transfer protein
12/10/2002	US6492360 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/10/2002	CA2230445C Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
12/10/2002	CA2109934C Substituted indoles as anti-aids pharmaceuticals
12/05/2002	WO2002096910A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
12/05/2002	WO2002096905A1 Thiazole compounds useful as inhibitors of protein kinases
12/05/2002	WO2002096904A1 Novel heterocyclic derivatives and medicinal use thereof
12/05/2002	WO2002096902A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/05/2002	WO2002096894A1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096880A1 Novel heterocyclic compound and medicinal use thereof
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	WO2002096420A2 Method for treating nerve injury caused by surgery
12/05/2002	WO2002096362A2 Method for treating fibrotic diseases or other indications vi
12/05/2002	WO2002096359A2 Piperazine pentanamide hiv protease inhibitors
12/05/2002	WO2002096358A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002	WO2002096317A2 Method for treating glaucoma vi
12/05/2002	WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002	WO2002074036A3 Substituted benzopyranones as telomerase inhibitors
12/05/2002	WO2002066450A3 Anthrone derivatives and their use as ink inhibitors
12/05/2002	WO2002051819A3 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183524 Preparations and use of an Ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
12/05/2002	US20020183371 Oxazolidinone combinatorial libraries, compositions and methods of preparation
12/05/2002	US20020183334 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder
12/05/2002	US20020183325 Phthalazinone derivatives
12/05/2002	US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002	US20020183317 Administering thiazole compound for therapy of fibrotic diseases
12/05/2002	US20020183309 For therapy of acute myocardial infarction, asthma, bipolar disorder, cognitive enhancement, cognitive deficits in psychiatric disorders, cutaneous carcinoma, drug abuse, depression, gastrointestinal disorders, inflammation
12/05/2002	US20020183307 For therapy of hyperlipidemic condition
12/05/2002	DE10126434A1 New tricyclic thiochromenone derivatives as metabotropic glutamate receptor-1 (mGluR1) antagonists useful for treating e.g. hemorrhagic stroke and atherosclerosis, especially pain or neurodegenerative diseases
12/05/2002	CA2449160A1 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
12/05/2002	CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	CA2449019A1 Method for treating nerve injury caused by surgery
12/05/2002	CA2448639A1 Novel heterocyclic derivatives and medicinal use thereof
12/05/2002	CA2448634A1 Novel heterocyclic compound and medicinal use thereof
12/05/2002	CA2448294A1 Method for treating fibrotic diseases or other indications vi
12/05/2002	CA2448276A1 Method for treating glaucoma vi
12/05/2002	CA2448103A1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
12/05/2002	CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	CA2447234A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/05/2002	CA2411549A1 Ligands of integrin receptors

1 ... 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 ... 628